Evidence map›Paper›PMID 29982375›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis.

Rein M G J Houben, Marek Lalli, Katharina Kranzer, Nick A Menzies, Samuel G Schumacher, David W Dowdy

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. A Systematic Review of Chronic Pulmonary Aspergillosis Among Patients Treated for Pulmonary Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Silicotuberculosis: a critical narrative review.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rein M G J HoubenTuberculosis Modelling Group, Tuberculosis Centre and Centre for Mathematical Modelling of Infectious Diseases.
Marek LalliTuberculosis Modelling Group, Tuberculosis Centre and Centre for Mathematical Modelling of Infectious Diseases.
Katharina KranzerInfectious Disease Epidemiology Department, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, United Kingdom.
Nick A MenziesDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Samuel G SchumacherFoundation for Innovative New Diagnostics, Geneva, Switzerland.
David W DowdyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Funding

Evaluating health and economic effects of targeted strategies in TB/HIVR01AI112438 · NIAID · YALE UNIVERSITY · PI COHEN, THEODORE H, SALOMON, JOSHUA A · 2014 to 2017
$2.4M
NIAID NIH HHS R01 AI112438
6 · The paper itself

Abstract

To find the millions of missed tuberculosis (TB) cases, national TB programs are under pressure to expand TB disease screening and to target populations with lower disease prevalence. Together with imperfect performance and application of existing diagnostic tools, including empirical diagnosis, broader screening risks placing individuals without TB on prolonged treatment. These false-positive diagnoses have profound consequences for TB patients and prevention efforts, yet are usually overlooked in policy decision making. In this article we describe the pathways to a false-positive TB diagnosis, including trade-offs involved in the development and application of diagnostic algorithms. We then consider the wide range of potential consequences for individuals, households, health systems, and reliability of surveillance data. Finally, we suggest practical steps that the TB community can take to reduce the frequency and potential harms of false-positive TB diagnosis and to more explicitly assess the trade-offs involved in the screening and diagnostic process.

Indexed as

Diagnostic ErrorsDiagnostic Tests, RoutineHumansMass ScreeningTuberculosis

Identifiers

PMID29982375
PMCPMC6293007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.